Komal Joshi

Chief Financial Officer

Komal Joshi is the Chief Financial Officer of Imbria Pharmaceuticals. She has over 20 years of finance leadership experience in life sciences as a Chief Financial Officer, as a healthcare investment banker and as an equity research analyst. Most recently, she was the Chief Financial Officer for LIB Therapeutics, a privately-held late-stage biopharmaceutical company. Komal has also held various positions of increasing strategic, financial and operational responsibility at private and public life science companies. As a healthcare investment banker, she has had broad transaction exposure, executing on capital raising and strategic advisory for emerging to large-cap companies across the healthcare industry. During her time in equity research, she covered Biotechnology, Medical Supplies and Devices as well as Enterprise Software. Komal holds an MBA from Columbia Business School and a BS from Boston College, Wallace E. Carroll School of Management.